Document Detail

Bezafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal beta-oxidation in rat white adipose tissue.
MedLine Citation:
PMID:  11216866     Owner:  NLM     Status:  MEDLINE    
Rats treated with bezafibrate, a PPAR activator, gain less body weight and increase daily food intake. Previously, we have related these changes to a shift of thermogenesis from brown adipose tissue to white adipose tissue attributable to bezafibrate, which induces uncoupling proteins (UCP), UCP-1 and UCP-3, in rat white adipocytes. Nevertheless, UCP induction was weak, implying additional mechanisms in the change of energy homeostasis produced by bezafibrate. Here we show that bezafibrate, in addition to inducing UCPs, modifies energy homeostasis by directly inducing aco gene expression and peroxisomal fatty acid beta-oxidation in white adipose tissue. Further, bezafibrate significantly reduced plasma triglyceride and leptin concentrations, without modifying the levels of PPARgamma or ob gene in white adipose tissue. These results indicate that bezafibrate reduces the amount of fatty acids available for triglyceride synthesis in white adipose tissue.
M Vázquez; N Roglans; A Cabrero; C Rodríguez; T Adzet; M Alegret; R M Sánchez; J C Laguna
Related Documents :
6541606 - In vitro conversion of androgen to estrogen in amphioxus gonadal tissues.
15372196 - Regeneration of pea (pisum sativum l.) by a cyclic organogenic system.
7346056 - Fatty acid composition of mammary gland lipids of lactating and nonlactating buffaloes.
1349716 - Esterification of fatty acids by bovine intramuscular and subcutaneous adipose tissues.
14628296 - Enantioresolution of fluorinated diphenylmethanols and determination of their absolute ...
1655086 - Synthesis and properties of the monomethyl ester of meso-dimercaptosuccinic acid and it...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Molecular and cellular biochemistry     Volume:  216     ISSN:  0300-8177     ISO Abbreviation:  Mol. Cell. Biochem.     Publication Date:  2001 Jan 
Date Detail:
Created Date:  2001-02-16     Completed Date:  2001-05-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0364456     Medline TA:  Mol Cell Biochem     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  71-8     Citation Subset:  IM    
Departamento Farmacología y Química Terapéutica, Facultad de Farmacia, Núcleo Universitario de Pedralbes, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acyl-CoA Oxidase
Adipose Tissue / metabolism*
Antilipemic Agents / pharmacology*
Bezafibrate / pharmacology*
Body Weight / drug effects
Cells, Cultured
Cholesterol / blood
Fatty Acids / metabolism*
Leptin / blood
Liver / drug effects,  metabolism
Oxidoreductases / metabolism*
Oxygen / metabolism*
Peroxisomes / metabolism*
RNA / metabolism
RNA, Messenger / metabolism
Rats, Sprague-Dawley
Receptors, Cytoplasmic and Nuclear / metabolism
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
Transcription Factors / metabolism
Triglycerides / blood
Reg. No./Substance:
0/Antilipemic Agents; 0/Fatty Acids; 0/Leptin; 0/RNA, Messenger; 0/Receptors, Cytoplasmic and Nuclear; 0/Transcription Factors; 0/Triglycerides; 41859-67-0/Bezafibrate; 57-88-5/Cholesterol; 63231-63-0/RNA; 7782-44-7/Oxygen; EC 1.-/Oxidoreductases; EC Oxidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hypothalamic GABA receptor functional regulation and liver cell proliferation.
Next Document:  Radiomodification of glyoxalase I in the liver and spleen of mice: adaptive response and split-dose ...